FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells
- PMID: 30355645
- PMCID: PMC6328860
- DOI: 10.1042/BSR20180906
FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells
Retraction in
-
Retraction: FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells.Biosci Rep. 2023 Jan 31;43(1):BSR-2018-0906_RET. doi: 10.1042/BSR-2018-0906_RET. Biosci Rep. 2023. PMID: 36714959 Free PMC article. No abstract available.
Abstract
Background: Accumulating studies discloses that long non-coding RNAs (lncRNAs) serve important roles in human tumorigenesis, including nasopharyngeal carcinoma (NPC). The purpose of the present study was to determine the role of lncRNA FEZF1-AS1 in NPC.
Materials and methods: The expression levels of FEZF1-AS1 in NPC tissues and cell lines were detected by RT-qPCR analysis. MTT assay was performed to investigate the proliferation of NPC cells in vitro, whereas the migration and invasion of NPC cells were determined by wound healing assay and transwell assay. A nude mouse tumor model was established to study the role of FEZF1-AS1 in NPC tumorigenesis in vivo The expression levels of proteins were detected by Western blot assay.
Results: The results showed that FEZF1-AS1 expression was increased in the NPC tissues and cell lines, and the higher expression of FEZF1-AS1 was closely associated with poor prognosis of NPC patients. We further observed that knockdown of FEZF1-AS1 inhibited the proliferation of NPC cells in vitro and suppressed NPC xenograft growth in vivo through inducing G2/M cell cycle arrest. The migratory and invasive abilities of NPC cells were also reduced upon FEZF1-AS1 knockdown. Moreover, we demonstrated that inhibition of FEZF1-AS1 remarkably suppressed epithelial-mesenchymal transition (EMT) and reduced β-catenin accumulation in nucleus in NPC cells.
Conclusions: Collectively, we showed that FEZF1-AS1 might be a key regulator of cell cycle, EMT and Wnt/β-catenin signaling in NPC cells, which may be helpful for understanding of pathogenesis of NPC.
Keywords: EMT; FEZF1-AS1; Wnt/β-catenin signaling; cell cycle; nasopharyngeal carcinoma.
© 2018 The Author(s).
Conflict of interest statement
The author declares that there are no competing interests associated with the manuscript.
Figures






Similar articles
-
FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignancies.Biosci Rep. 2019 Jun 25;39(6):BSR20191202. doi: 10.1042/BSR20191202. Print 2019 Jun 28. Biosci Rep. 2019. PMID: 31175144 Free PMC article. Review.
-
Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.Aging (Albany NY). 2021 May 23;13(10):13726-13738. doi: 10.18632/aging.202960. Epub 2021 May 23. Aging (Albany NY). 2021. PMID: 34023817 Free PMC article.
-
MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.J Exp Clin Cancer Res. 2019 Feb 21;38(1):97. doi: 10.1186/s13046-019-1023-4. J Exp Clin Cancer Res. 2019. Retraction in: J Exp Clin Cancer Res. 2021 Sep 30;40(1):309. doi: 10.1186/s13046-021-02113-3. PMID: 30791932 Free PMC article. Retracted. Clinical Trial.
-
Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.Mol Cancer. 2019 Jan 22;18(1):15. doi: 10.1186/s12943-019-0942-1. Mol Cancer. 2019. PMID: 30670025 Free PMC article.
-
Pathological role of long non-coding (lnc) RNA in the regulation of Wnt/β-catenin signaling pathway during epithelial-mesenchymal transition (EMT).Pathol Res Pract. 2023 Aug;248:154566. doi: 10.1016/j.prp.2023.154566. Epub 2023 May 24. Pathol Res Pract. 2023. PMID: 37285735 Review.
Cited by
-
FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignancies.Biosci Rep. 2019 Jun 25;39(6):BSR20191202. doi: 10.1042/BSR20191202. Print 2019 Jun 28. Biosci Rep. 2019. PMID: 31175144 Free PMC article. Review.
-
FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma.Biosci Rep. 2019 May 31;39(5):BSR20190754. doi: 10.1042/BSR20190754. Print 2019 May 31. Biosci Rep. 2019. PMID: 31076545 Free PMC article.
-
Multiple Mechanisms Involving in Radioresistance of Nasopharyngeal Carcinoma.J Cancer. 2020 Apr 25;11(14):4193-4204. doi: 10.7150/jca.39354. eCollection 2020. J Cancer. 2020. PMID: 32368302 Free PMC article. Review.
-
Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities.Int J Biol Sci. 2022 Mar 28;18(7):2714-2728. doi: 10.7150/ijbs.70292. eCollection 2022. Int J Biol Sci. 2022. PMID: 35541920 Free PMC article. Review.
-
Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.Aging (Albany NY). 2021 May 23;13(10):13726-13738. doi: 10.18632/aging.202960. Epub 2021 May 23. Aging (Albany NY). 2021. PMID: 34023817 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous